Business Wire

Anavasi Diagnostics Receives FDA Emergency Use Authorization for The AscencioDx COVID-19 Test and The AscencioDx Molecular Detector

REDMOND, Wash.--(BUSINESS WIRE)--Anavasi Diagnostics, an NIH/RADx funded medical technology company developing novel molecular diagnostic testing for the point-of-care (POC) market, announced the Food ...
Jackson Hole Community Radio - KHOL 89.1 FM

Jackson-based lab is developing a blood test to help diagnose ALS

According to Brain Chemistry Labs, the in-the-works test can identify an ALS patient with 97% accuracy. The next step is to ...
Business Wire

Cue Health Receives FDA Emergency Use Authorization for Molecular Mpox Test

SAN DIEGO--(BUSINESS WIRE)--Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced it has received Emergency Use Authorization (EUA) from the United States Food and Drug ...
Medscape

Molecular Testing in Dermatology: Who and When to Test

SEATTLE — Molecular testing has been widely integrated into mainstream healthcare, and its use is increasing in dermatology. It can help differentiate between skin conditions, for example, as some ...
Seeking Alpha

Quest Diagnostics set to launch a rapid lab test to detect avian influenza A H5 virus

Quest Diagnostics (NYSE:DGX) announced on Wednesday that it will roll out a rapid molecular lab test to detect the avian influenza A H5 virus. This initiative is part of an award from the U.S. Centers ...